著者
立花 修
出版者
Kinki Brain Tumor Pathology Conference
雑誌
Neuro-Oncologyの進歩 (ISSN:18800742)
巻号頁・発行日
vol.22, no.2, pp.12-21, 2015-09-12 (Released:2015-09-12)
参考文献数
53

Rathke cleft cysts (RCCs) are benign cystic lesions of the sella that arise from remnants of the embryonic Rathke residual pouch. RCCs are common incidental findings in 4-33% of autopsy cases and on imaging, and most remain asymptomatic. However, RCCs can become sufficiently large and rupture to cause severe headache, visual field defects and hypothalamic pituitary dysfunctions. Asymptomatic RCCs are typically followed by serial imaging, while symptomatic RCCs are managed by surgical decompression. Although a headache and the visual disturbance are improved by surgical treatment, the pituitary insufficiency is not often improved. It is thought that an irreversible disorder due to the local chronic inflammation involves the pituitary gland. MRI reveals well-demarcated homogenous lesions with variable intensity that is highly dependent on the protein concentration of cyst contents, which can range from clear, CSF-like fluid to thick, mucoid material. Rates of recurrence after surgical treatment range from 11 to 18 % in large series, and higher rates of recurrence are associated with inflammation and reactive squamous metaplasia in the cyst wall. As the natural history of RCCs remains unclear and the mechanism of progression of these cysts is not understood, it might be difficult to determine when we should do the intervention of the surgery.
著者
立花 修
出版者
金沢医科大学
雑誌
基盤研究(C)
巻号頁・発行日
2010

視力視野障害やホルモン分泌不全を呈する、症候性ラトケ嚢胞の嚢胞増大機序の一つに、水チャンネルを司るアクアポリンが関与していることが判明した。また、ラトケ上皮細胞がアンドロジェン受容体を発現することにより、下垂体での炎症の誘発、ラトケ上皮の増殖に関与すると推測された。アクアポリンやアンドロジェン受容体は、症候性ラトケ嚢胞の治療における標的分子となりうると考えられた。